Randomized Controlled Trial
Copyright ©The Author(s) 2015.
World J Gastroenterol. Dec 7, 2015; 21(45): 12888-12895
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12888
Table 1 Characteristics of the patients in the infection and control groups
Infection group
StatisticP valueControl group
StatisticP value
ABCDABCD
(n = 19)(n = 19)(n 19)(n = 19)(n = 20)(n = 20)(n = 20)(n = 20)
Age (yr)59.9 ± 11.263.1 ± 9.266.1 ± 10.966.0 ± 12.5F = 1.3410.26858.7 ± 12.162.0 ± 8.565.2 ± 10.761.7 ± 14.1F = 1.0810.362
Sex (M:F)12:714:514:513:6χ2 = 0.6860.87715:514:615:513:7χ2 = 0.6710.880
Indication for gastrectomyχ2 = 0.4520.929χ2 = 0.2510.969
Peptic ulcer7867--5656--
Early-stage gastric cancer12111312--15141514--
Reconstructive procedure----
B-I11111111--10101010--
B-II8888--10101010--
Interval (yr)8.9 ± 5.97.4 ± 5.17.3 ± 3.97.9 ± 4.9F = 0.4290.7338.6 ± 6.07.6 ± 5.87.8 ± 5.08.4 ± 4.6F = 0.1500.929
Table 2 The reconstructive procedure and mean delta over baseline values (‰) for the subjects in the infection group
SubgroupTimeDOB ( B-I)DOB ( B-II)t valueP value
AT59.67 ± 1.799.30 ± 3.000.3140.760
T1012.57 ± 1.9212.18 ± 3.060.3240.752
T1512.28 ± 1.9511.89 ± 3.080.3190.756
T2011.50 ± 1.9310.80 ± 2.940.5880.568
T2510.91 ± 1.9010.20 ± 2.980.5920.566
T3010.58 ± 1.889.86 ± 2.930.6090.555
BT59.74 ± 2.338.74 ± 2.850.8410.412
T1010.69 ± 2.1110.01 ± 2.600.6280.538
T1514.20 ± 1.5613.56 ± 1.560.8800.391
T2013.99 ± 1.5913.35 ± 1.620.8610.401
T2513.57 ± 1.6012.91 ± 1.620.8850.389
T3013.34 ± 1.5612.69 ± 1.590.8900.386
CT58.96 ± 1.698.69 ± 1.710.3440.735
T1010.03 ± 1.539.81 ± 1.670.2880.777
T1512.33 ± 1.7412.05 ± 1.730.3470.733
T2011.79 ± 1.6911.50 ± 1.720.3640.720
T2511.26 ± 1.6210.99 ± 1.690.3520.729
T3010.95 ± 1.6210.72 ± 1.620.2950.771
DT510.21 ± 1.548.39 ± 2.182.1360.048
T1012.12 ± 1.579.98 ± 2.562.4460.026
T1514.51 ± 1.3912.91 ± 1.762.2130.041
T2015.32 ± 1.3713.83 ± 1.822.0490.056
T2515.04 ± 1.3813.56 ± 1.772.0570.055
T3014.84 ± 1.3713.33 ± 1.822.0680.054